The economic cost of obesity is expected to soar to $4 trillion by 2035. Weight loss drugs like Ozempic could change that, Goldman Sachs says.

"By fighting obesity, these drugs seem to be fighting heart disease, which is the leading cause of death," Goldman Sachs said.

https://www.businessinsider.com/obesity-economic-cost-4-trillion-wegovy-ozempic-weight-loss-drugs-2023-9